Perspectives in the biological function, the technical and therapeutic application of bone morphogenetic proteins

Applied Microbiology and Biotechnology

Volumn 57, Issue 3, 2001, Pages 294-308

  Hoffmann, A ^a   Weich, H A ^a   Gross, G ^a   Hillmann, G ^b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GLASS; GROWTH DIFFERENTIATION FACTOR 5; GROWTH DIFFERENTIATION FACTOR 6; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1; OSTEOGENIC PROTEIN 2; POLYMER; RECOMBINANT PROTEIN; SMAD PROTEIN; TETRAMER; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE; PROTEIN;

BONE DEVELOPMENT; BONE DISEASE; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; CELL MATURATION; CHONDROGENESIS; DRUG DELIVERY SYSTEM; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; FRACTURE; HUMAN; LIGAND BINDING; MESENCHYME; NONHUMAN; ORGANOGENESIS; OSSIFICATION; PERIODONTAL DISEASE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; STEM CELL; TOOTH DEVELOPMENT; VERTEBRATE;

ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; FRACTURE HEALING; HUMANS; MICE; PERIODONTAL DISEASES; RECOMBINANT PROTEINS;

VERTEBRATA;

EID: 0034793089     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002530100746     Document Type: Article

References (159)

1. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages
2. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes
3. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer
4. Activation of signalling by the activin receptor complex
5. Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2)
6. A novel mesoderm inducer, Madr2 functions in the activin signal transduction pathway
7. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily
8. Histologic findings after implantation and evaluation of different grafting materials and titanium micro screws into extraction sockets: Case reports
9. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor
10. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation
11. Early histological and ultrastructural changes in medullary fracture callus
12. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy
13. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
14. Mesenchymal stem cells
15. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice
16. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin
17. Identification of transforming growth factor-β family members present in bone-inductive protein purified from bovine bone
18. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
19. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors
20. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans
21. Torsional stability of HA-coated and grit-blasted titanium dental implants
22. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites
23. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates
24. 1 mRNA expression
25. Bone morphogenetic protein-3 is a negative regulator of bone density
26. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated growth factor beta-mediated signal transduction
27. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives
28. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse
29. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye
30. Enhancement of fracture-healing
31. Roles of bone morphogenetic protein type I receptors and smad proteins in osteoblast and chondroblast differentiation
32. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner
33. Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass and tricalcium phosphate implanted in sheep diaphyseal defects
34. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen
35. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy
36. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect
37. Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor b superfamily
38. Bone morphogenetic proteins in human bone regeneration
39. Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralized bone matrix or autogenous bone. Comparison with non-grafted sites in a series of case reports
40. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
41. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates
42. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils
43. The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFβ signaling
44. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system
45. TGF-β signalling from cell membrane to nucleus through SMAD proteins
46. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling
47. Transforming growth factor beta 1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2
48. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro
49. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
50. Poly(α-hydroxy acids): Carriers for bone morphogenetic proteins
51. Sustained release emphasizing recombinant human bone morphogenetic protein-2
52. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation
53. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities
54. Ectopic bone induction in porous apatite-wollastonite-containing glass ceramic combined with bone morphogenetic protein
55. Smad6 inhibits signalling by the TGF-b superfamily
56. One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein
57. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion
58. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2
59. Bioabsorbable scaffolds for guided bone regeneration and generation
60. Bone morphogenetic protein-1: The type I procollagen C-proteinase
61. The foreign body reaction to a biodegradable biomaterial differs between rats and mice
62. Enzyme and cytokine effects on the impaired onset of the murine foreign-body reaction to dermal sheep collagen
63. Drosophila MAD binds to DNA and directly mediates activation of vestigial by decapentaplegic
64. The effect of root surface demineralization on bone morphogenetic protein-2-induced healing of rat periodontal fenestration defects
65. The TGF-b superfamily: New members, new receptors, and new genetic tests of function in different organisms
66. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF-β superfamily
67. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs
68. Herstellung und Biologie der bone morphogenetic proteins
69. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system
70. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis
71. A human Mad protein acting as a BMP-regulated transcriptional activator
72. Beta-glycan can act as a dual modulator of TGF-beta access to signaling receptors: Mapping of ligand binding and GAG attachment sites
73. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
74. Modulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats
75. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network
76. Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development
77. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
78. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats
79. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral
80. Production of functional human bone morphogenetic protein-2 using a baculovirus/Sf-9 insect cell system
81. TGF-β signal transduction
82. Controlling TGF-beta signaling
83. Transcriptional control by the TGF-beta/Smad signaling system
84. The TGF-b family and its composite receptors
85. Scanning electron and light microscopic observations on the healing process after sintered bone implantation in rats
86. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier
87. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
88. The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation
89. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2
90. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis
91. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen
92. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2 beta1 integrin interaction
93. Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum
94. Identification of Smad7, a TGFβ -inducible antagonist of TGF-β signalling
95. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2
96. Interface mechanics and histomorphometric analysis of hydroxyapatite-coated and porous glass-ceramic implants in canine bone
97. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12
98. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
99. Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2)
100. Biological activity of rhBMP-2 released from PLGA microspheres
101. Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: Potentiation and binding to type IV collagen
102. Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-β superfamily. Selective effects of the bone morphogenetic proteins
103. Specificity, diversity, and regulation in TGF-beta superfamily signaling
104. Regulation of left-right patterning in mice by growth/differentiation factor-1
105. Regulation of cartilage and bone differentiation by bone morphogenetic proteins
106. Establishment and characterization of a cloned cell line of C3H mouse embryo cells sensitive to postconfluence inhibition of division
107. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7)
108. Long-term evaluation of bone formation by osteogenic protein 1 in the baboon and relative efficacy of bone-derived bone morphogenetic proteins delivered by irradiated xenogeneic collagenous matrices
109. Cloning and characterization of a human type II receptor for bone morphogenetic proteins
110. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity
111. New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D, L-lactic acid-polyethylene glycol block copolymers
112. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation
113. BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo
114. BMPs induce endochondral ossification in rats when implanted ectopically within a carrier made of fibrous glass membrane
115. Crystal structure of human bone morphogenetic protein-2 at 2.7 angstrom resolution
116. Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2
117. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems
118. Reconstruction of the primate mandible with a combination graft of recombinant human bone morphogenetic protein-2 and bone marrow
119. The role of type I collagen in the regulation of the osteoblast phenotype
120. Biodegradation and biocompatibility of PLA and PLGA microspheres
121. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers
122. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo
123. Mice lacking Bmp6 function
124. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily
125. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein
126. Characterization of type I receptors for transforming growth factor-b and activin
127. Identification of type I receptors for osteogenic protein- 1 and bone morphogenetic protein-4
128. A human chondrodysplasia due to a mutation in a TGF-β superfamily member
129. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation
130. SARA, a FYVE domain protein that recruits Smad2 to the TGF beta receptor
131. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis
132. Bone formation by autoinduction
133. Bone morphogenetic protein
134. Solubilized and insolubilized bone morphogenetic proteins
135. Bone cell differentiation and growth factors
136. Beta-tricalcium phosphate delivery system for bone morphogenetic protein
137. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs
138. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells
139. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin
140. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
141. Purification and characterization of other distinct bone-inducing factors
142. Recombinant human bone morphogenetic protein induces bone formation
143. Bone morphogenetic protein causes commitment and differentiation in C3H10T1/2 and 3T3 cells
144. Carrier systems for bone morphogenetic proteins
145. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse
146. Bone morphogenetic proteins
147. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair
148. Novel regulators of bone formation, molecular clones and activities
149. Mechanism of activation of the TGF-β receptor
150. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris
151. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
152. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
153. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats
154. The type IBMP receptor BMPRIB is required for chondrogenesis in the mouse limb
155. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)
156. Mice deficient for BMP2 are nonvia-ble and have defects in amnion/chorion and cardiac development
157. Characterization of GDF-10 expression patterns and null mice
158. Smad3 mutant mice develop metastatic colorectal cancer
159. The Spe-mann organizer signal noggin binds and inactivates bone mor-phogenetic protein 4